Nationwide Fund Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,399
Closed -$369K 2009
2017
Q3
$369K Sell
6,399
-190
-3% -$11.2K ﹤0.01% 2333
2017
Q2
$422K Buy
6,589
+457
+7% +$28.2K ﹤0.01% 2267
2017
Q1
$353K Sell
6,132
-369
-6% -$22K ﹤0.01% 2341
2016
Q4
$398K Sell
6,501
-493
-7% -$32.1K ﹤0.01% 2302
2016
Q3
$484K Hold
6,994
﹤0.01% 2196
2016
Q2
$390K Sell
6,994
-312
-4% -$18.8K ﹤0.01% 2280
2016
Q1
$444K Sell
7,306
-204
-3% -$12K ﹤0.01% 2157
2015
Q4
$480K Buy
7,510
+142
+2% +$9.21K ﹤0.01% 2136
2015
Q3
$494K Hold
7,368
﹤0.01% 2128
2015
Q2
$503K Sell
7,368
-1,022
-12% -$64.9K ﹤0.01% 2243
2015
Q1
$466K Sell
8,390
-314
-4% -$16.1K ﹤0.01% 2269
2014
Q4
$446K Sell
8,704
-656
-7% -$32.2K ﹤0.01% 2245
2014
Q3
$345K Sell
9,360
-488
-5% -$17.6K ﹤0.01% 2424
2014
Q2
$385K Buy
9,848
+566
+6% +$21K ﹤0.01% 2404
2014
Q1
$350K Hold
9,282
﹤0.01% 2232
2013
Q4
$351K Sell
9,282
-316
-3% -$12.1K ﹤0.01% 2403
2013
Q3
$417K Buy
9,598
+984
+11% +$39.5K ﹤0.01% 2309
2013
Q2
$312K Buy
+8,614
New +$262K ﹤0.01% 2277

Other funds holding USNA

Nationwide Fund Advisors's USNA Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Usana Health Sciences (USNA) in Q4 2017, closing a stake of 6,399 shares — an estimated $369K sold.

Nationwide Fund Advisors first reported a position in USNA in Q2 2013 and held it in 18 quarters. The position peaked at $503K in Q2 2015. 151 funds tracked by Wall St. Rank hold USNA as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Usana Health Sciences position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 6,399 Usana Health Sciences shares in Q4 2017, an estimated $369K.
  • Nationwide Fund Advisors first reported a position in Usana Health Sciences in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Usana Health Sciences position peaked at $503K in Q2 2015.
  • 151 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.